BPC-157 affects the whole body through systemic activity across the gastrointestinal tract, central nervous system, vascular system, and musculoskeletal tissue, extending its effects well beyond the local injury site
Antiemetics Nausea and vomiting are the most disabling symptoms of gastroparesis, and antiemetic agents without stimulatory activity are often used alone or in combination with prokinetic drugs to treat gastroparesis
It is currently one of the most studied next-generation peptides in metabolic research
:
Nonetheless, whether the specific mechanism of this is related to the transdifferentiation of VSMCs to a bone-like phenotype, loss in SMC lineage markers, enhanced pro-calcific microRNAs, increased intracellular calcium level, apoptosis, or aberrant DNA damage response (DDR) requires further investigation